Michael A Vogelbaum
Overview
Explore the profile of Michael A Vogelbaum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
271
Citations
12812
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ugolini A, De Leo A, Yu X, Scirocchi F, Liu X, Peixoto B, et al.
Cancer Discov
. 2025 Feb;
PMID: 40014923
Despite functional heterogeneity, high frequency of intratumoral neutrophils predicts poor clinical outcomes. The tumor microenvironment reprograms neutrophils into immunosuppressive subsets that hinder anti-cancer immunity, thereby contributing to tumor growth and...
2.
Kotecha R, Akdemir E, Kutuk T, Ilgin C, Ahluwalia M, Bi W, et al.
Neuro Oncol
. 2025 Jan;
PMID: 39807850
Background: Despite advances in our understanding of the molecular underpinnings of meningioma progression and innovations in systemic and local treatments, recurrent meningiomas remain a substantial therapeutic challenge. The objective of...
3.
Verger A, Tolboom N, Cicone F, Chang S, Furtner J, Galldiks N, et al.
Eur J Nucl Med Mol Imaging
. 2025 Jan;
PMID: 39762634
This joint practice guideline/procedure standard was collaboratively developed by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neuro-Oncology...
4.
Ellingson B, Sanvito F, Pope W, Cloughesy T, Huang R, Villanueva-Meyer J, et al.
AJNR Am J Neuroradiol
. 2024 Dec;
46(1):221-222.
PMID: 39730160
No abstract available.
5.
Kotecha R, La Rosa A, Brown P, Vogelbaum M, Navarria P, Bodensohn R, et al.
Neuro Oncol
. 2024 Nov;
27(3):597-615.
PMID: 39495010
As cancer patients with intracranial metastatic disease experience increasingly prolonged survival, the diagnosis and management of recurrent brain metastasis pose significant challenges in clinical practice. Prior to deciding upon a...
6.
Karschnia P, Young J, Youssef G, Dono A, Hani L, Sciortino T, et al.
Neuro Oncol
. 2024 Nov;
PMID: 39492786
Background: Following surgery, patients with newly diagnosed glioblastoma frequently enter clinical trials. Nuanced risk assessment is warranted to reduce imbalances between study arms. Here, we aimed (I) to analyze the...
7.
Villanueva-Meyer J, Bakas S, Tiwari P, Lupo J, Calabrese E, Davatzikos C, et al.
Lancet Oncol
. 2024 Oct;
25(11):e581-e588.
PMID: 39481414
The development, application, and benchmarking of artificial intelligence (AI) tools to improve diagnosis, prognostication, and therapy in neuro-oncology are increasing at a rapid pace. This Policy Review provides an overview...
8.
Ghisai S, van Hijfte L, Vallentgoed W, Tesileanu C, de Heer I, Kros J, et al.
Acta Neuropathol
. 2024 Oct;
148(1):50.
PMID: 39382765
Accurate grading of IDH-mutant gliomas defines patient prognosis and guides the treatment path. Histological grading is challenging, and aside from CDKN2A/B homozygous deletions in IDH-mutant astrocytomas, there are no other...
9.
Hotchkiss K, Karschnia P, Schreck K, Geurts M, Cloughesy T, Huse J, et al.
Lancet Oncol
. 2024 Oct;
25(10):e512-e519.
PMID: 39362262
Patients with brain tumours are motivated to participate in clinical trials involving repeat tissue sampling. Normalising the use of neoadjuvant and staged surgical trials necessitates collaboration among patients, regulatory agencies,...
10.
Jarmula J, Lee J, Lauko A, Rajappa P, Grabowski M, Dhawan A, et al.
Neurooncol Adv
. 2024 Sep;
6(1):vdae142.
PMID: 39233830
Primary central nervous system (CNS) tumors affect tens of thousands of patients each year, and there is a significant need for new treatments. Macrophage migration inhibitory factor (MIF) is a...